The research interests of Wayne L. Miller, M.D., Ph.D., relate to acute and chronic heart failure and acute coronary syndromes.
Dr. Miller is a Fellow of the American College of Cardiology and the American Heart Association.
- Ongoing research includes the study of biomarkers, such as cardiac troponins, and natriuretic peptides, such as B-type natriuretic peptide (BNP), atrial natriuretic peptide (ANP) and proBNP, as prognostic markers and indicators of treatment efficacy.
- Dr. Miller also examines both long-term serial measurements and short-term acute responses to therapy. In addition, he has assessed biomarkers and neurohormones in cardiomyopathy of different etiologies, such as ischemic, idiopathic and amyloidosis.
- Additional research includes assessment of BNP infusion therapy in acute decompensated heart failure of differing etiologies.
- Dr. Miller also has a clinical and research interest in intravascular volume assessment and management in patients with chronic heart failure with both reduced and preserved left ventricular ejection fraction. This research has implications in the optimal management of volume overload and congestion in patients with heart failure.
Significance to patient care
Dr. Miller's research program is integrated with clinical research and care for patients in Mayo's outpatient Heart Failure Clinic and inpatient hospital services for heart failure patients.